| Pharmaceutical Information |
| Drug Name |
Rasburicase |
| Drug ID |
BADD_D01917 |
| Description |
Rasburicase is a recombinant urate-oxidase enzyme produced by a genetically modified Saccharomyces cerevisiae strain. The cDNA coding for rasburicase was cloned from a strain of _Aspergillus flavus_. |
| Indications and Usage |
For treatment of hyperuricemia, reduces elevated plasma uric acid levels (from chemotherapy) |
| Marketing Status |
Prescription |
| ATC Code |
V03AF07 |
| DrugBank ID |
DB00049
|
| KEGG ID |
D05704
|
| MeSH ID |
C469709
|
| PubChem ID |
Not Available
|
| TTD Drug ID |
D08LJP
|
| NDC Product Code |
0024-5151; 0024-5150 |
| Synonyms |
rasburicase | Elitek | Fasturtec |
|
| Chemical Information |
| Molecular Formula |
Not Available |
| CAS Registry Number |
134774-45-1 |
| SMILES |
Not Available |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
|
|
| ADRs Induced by Drug |
|
|
